Key terms
About MORF
Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MORF news
Mar 19
8:04am ET
Morphic appoints Cooper as Chief Medical Officer
Mar 12
5:02pm ET
Morphic Holding Unveils Updated Corporate Presentation
Mar 11
7:30am ET
Analysts Offer Insights on Healthcare Companies: MoonLake Immunotherapeutics (MLTX) and Morphic Holding (MORF)
Mar 11
7:09am ET
Morphic Holding: A Strong Buy on Robust Financials and Promising Clinical Trials
Mar 08
7:55am ET
Morphic Holding: Strong Financials and Promising Clinical Trials Reinforce Buy Rating
Mar 08
7:47am ET
Morphic price target lowered to $66 from $68 at Canaccord
Feb 26
8:50pm ET
Analysts Offer Insights on Healthcare Companies: Morphic Holding (MORF) and Vertex Pharmaceuticals (VRTX)
Feb 26
6:30am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Celldex (CLDX), Abbott Labs (ABT) and Morphic Holding (MORF)
Feb 25
11:25pm ET
Morphic Holding’s Strong Clinical Progress and Financial Stability Support Buy Rating
Feb 23
7:36am ET
Morphic price target lowered to $64 from $67 at Wells Fargo
Feb 23
5:59am ET
Morphic Holding’s Buy Rating Affirmed on Strong Clinical and Financial Prospects
Feb 22
3:20pm ET
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR) and Morphic Holding (MORF)
Feb 22
7:15am ET
Morphic reports FY23 revenue $521,000, consensus $500,000
Jan 07
5:41am ET
Morphic Holding (MORF) Receives a Hold from BTIG
Jan 02
9:34am ET
BTIG Remains a Hold on Morphic Holding (MORF)
Dec 31
5:20am ET
BTIG Sticks to Their Hold Rating for Morphic Holding (MORF)
Apr 16
11:30pm ET
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Morphic Holding, Inc. and Encourages Investors with Losses to Contact the Firm
Apr 15
3:00am ET
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Morphic Holding, Inc. and Encourages Investors with Losses to Contact the Firm
Apr 11
3:30am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Morphic Holding, Inc. and Encourages Investors with Losses to Contact the Firm
MORF Financials
Key terms
Ad Feedback
MORF Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MORF Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
